Regulatory Prototype for Biological Products in the United States
G. M. Pavithra & N. Venugopal · Journal of Pharmaceutical Research International · 2021
Biological products are used for the treatment of many disease, so the biological application submitted for the approval of products are also increasing. The progress of a biosimilarproduct is more difficult and expensive than a small molecule generic product. Biosimilars are not...
Open access
Research Article
10.9734/jpri/2021/v33i28B31539